Koers Fuse Medical, Inc.
Aandelen
FZMD
US36113U1016
Medische apparatuur, benodigdheden & distributie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,0988 USD | +3,95% | +4,00% | -14,09% |
Omzet 2021 | 20,41 mln. 19,07 mln. | Omzet 2022 | 18,64 mln. 17,42 mln. | Marktkapitalisatie | 10,55 mln. 9,86 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -1 mln. -934K | Nettowinst (verlies) 2022 | 3 mln. 2,8 mln. | EV/omzet 2021 | 1,59 x |
Nettoschuld 2021 | 2,23 mln. 2,08 mln. | Nettoschuld 2022 | 2,2 mln. 2,05 mln. | EV/omzet 2022 | 0,68 x |
K/w-verhouding 2021 |
-19
x | K/w-verhouding 2022 |
3,75
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 13,11% |
1 dag | +3,95% | ||
1 week | +4,00% | ||
Lopende maand | -17,67% | ||
1 maand | -17,67% | ||
3 maanden | -4,63% | ||
6 maanden | -41,81% | ||
Lopend jaar | -14,09% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Christopher Reeg
CEO | Chief Executive Officer | 60 | 19-12-16 |
Mark Brooks
CHM | Chairman | 58 | 19-12-16 |
Lawrence Yellin
DFI | Director of Finance/CFO | 66 | 04-04-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lawrence Yellin
DFI | Director of Finance/CFO | 66 | 04-04-22 |
Christopher Reeg
CEO | Chief Executive Officer | 60 | 19-12-16 |
Mark Brooks
CHM | Chairman | 58 | 19-12-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-14,09% | 6,94 mln. | |
-2,89% | 187 mld. | |
-2,43% | 108 mld. | |
-4,10% | 67,71 mld. | |
+11,10% | 53,07 mld. | |
+15,86% | 47,36 mld. | |
+3,74% | 39,73 mld. | |
+9,55% | 28,56 mld. | |
+1,85% | 26,55 mld. | |
+14,63% | 25,13 mld. |